Evidence map›Paper›PMID 37200842›Full record

ReviewFrontiers in bioengineering and biotechnology2023

Biofabrication of nanoparticles: sources, synthesis, and biomedical applications.

Deepak Kulkarni, Rushikesh Sherkar, Chaitali Shirsathe, Rushikesh Sonwane, Nikita Varpe, Santosh Shelke, Mahesh P More, Sagar R Pardeshi, Gargee Dhaneshwar, Vijayabhaskarreddy Junnuthula and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Deepak KulkarniDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Rushikesh SherkarDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Chaitali ShirsatheDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Rushikesh SonwaneDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Nikita VarpeDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Santosh ShelkeDepartment of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India.
Mahesh P MoreDepartment of Pharmaceutics, Dr Rajendra Gode College of Pharmacy, Malkapur, Buldana, India.
Sagar R PardeshiDepartment of Pharmaceutics, St John Institute of Pharmacy and Research, Palghar, India.
Gargee DhaneshwarMET's Institute of Pharmacy, Nashik, Maharashtra, India.
Vijayabhaskarreddy JunnuthulaDrug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Sathish DyawanapellyDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is an emerging applied science delivering crucial human interventions. Biogenic nanoparticles produced from natural sources have received attraction in recent times due to their positive attributes in both health and the environment. It is possible to produce nanoparticles using various microorganisms, plants, and marine sources. The bioreduction mechanism is generally employed for intra/extracellular synthesis of biogenic nanoparticles. Various biogenic sources have tremendous bioreduction potential, and capping agents impart stability. The obtained nanoparticles are typically characterized by conventional physical and chemical analysis techniques. Various process parameters, such as sources, ions, and temperature incubation periods, affect the production process. Unit operations such as filtration, purification, and drying play a role in the scale-up setup. Biogenic nanoparticles have extensive biomedical and healthcare applications. In this review, we summarized various sources, synthetic processes, and biomedical applications of metal nanoparticles produced by biogenic synthesis. We highlighted some of the patented inventions and their applications. The applications range from drug delivery to biosensing in various therapeutics and diagnostics. Although biogenic nanoparticles appear to be superior to their counterparts, the molecular mechanism degradation pathways, kinetics, and biodistribution are often missing in the published literature, and scientists should focus more on these aspects to move them from the bench side to clinics.

Indexed as

biogenic synthesisbiomedical applicationsgreen synthesismetallic nanoparticlesmicroorganismsnanoparticlesnatural sourcesplant extracts

Identifiers

PMID37200842
PMCPMC10185809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.